ENGLISH
Abbott Header Logo
Logo Image

Infectious disease

Get in touch
Infectious disease banner image
Infectious disease banner image
Infectious disease banner image

HIV's rapid evolution leads to genetic variations among different subtypes, differing by 25-35%1 

Viral hepatitis was the second leading cause of death from communicable diseases in 20222 

Despite nearing eradication, syphilis has reached crisis levels again, with 8M new infections globally in 20223 

Since 1980, new pathogens causing disease in humans has emerged at a rate of over 3 per year4

Viruses evolve. We monitor them so you don't have to.

Abbott’s Global Viral Surveillance Program has been at the forefront of monitoring HIV and Hepatitis since 1994. 

But as viruses continue to mutate and move around the world faster than ever before, we have expanded our efforts to respond more quickly through the Abbott Pandemic Defense Coalition. 

This first-of-its-kind global network, led by industry, is dedicated to end current epidemics and help prevent future pandemics, giving laboratorians, clinicians, and communities confidence for today and protection for tomorrow.

Abbott Pandemic Defense Coalition map
Abbott Pandemic Defense Coalition map

Confidence for today, protection for tomorrow

Through heritage, innovation and understanding, Abbott offers clinical confidence in the fight against infectious diseases.

Guided by Abbott's history of innovation, our experts collaborate to overcome todays' infectious disease challenges and work to continually improve our diagnostic accuracy. Our comprehensive understanding of the rapidly changing infectious disease landscape is key to delivering clinical confidence and brings every person affected closer to the care they need.

HIV

HIV

Diagnosing HIV-positive individuals is critical to connect them to treatment and prevent the ongoing spread of infection so we can help end the HIV epidemic. Abbott's HIV assays enhance lab capabilities to confidently identify the virus, regardless of where it originated.

Hepatitis Solutions

Hepatitis Solutions

Our HAV, HBV and HCV assays are designed to overcome the viral hepatitis diagnostic challenges and help streamline the journey from diagnosis to care, supporting viral hepatitis elimination goals.

Visit Hepatitis

Syphilis

In the battle against the syphilis epidemic,  timely and accurate testing plays a crucial role in early detection and treatment. Our automated solution provides accurate results, streamlines the diagnostic process, and enhances efficiency.

TORCH Panel

Confidently detect TORCH infections early in pregnancy to minimize mother-to-child transmission risks. Abbott's TORCH panel provides accurate results and streamlines lab workflows.

Visit TORCH

SARS-CoV-2 Immunoassays

Coming off the COVID-19 pandemic, SARS-CoV-2 antibody testing can provide additional options to test patients and conduct ongoing research to understand the effects of the disease.

Visit SARS-CoV-2
Core Laboratory Menu and Systems

 

View and download the Core Laboratory menus to see the complete list of available assays and in development assays, categorized by instrument.

Some assays may not be available on all platforms or in all regions.

Alinity Menu
ARCHITECT Menu

 

Hepatitis
Anti-HBc
Anti-HBc IgM
Anti-HBc II
Anti-HBe
Anti-HBs
Anti-HCV
HAVAb IgG
HAVAb IgM
HBeAg
HBeAg Qualitative/Quantitative
HBsAg Quantitative
HBsAg Quantitative Confirmatory
HBsAg Next Confirmatory
HBsAg Next Qualitative
HBsAg Qualitative II
HBsAg Qualitative II Confirmatory
HCV Ag

 

Other Infectious Disease
Chagas
EBV EBNA-1-IgG
EBV VCA IgG
EBV VCA IgM
SARS-COV-2 IGG
SARS-COV-2 IgG II Quant
SARS-COV-2 IGM
Syphilis TP

 

 

 

RETROVIRUS
Anti-HTLV I/II
HIV Ag/Ab Combo
rHTLV-I/II

 

TORCH
CMV IgG
CMV IgG Avidity
CMV IgM
HSV-1 IgG
HSV-2 IgG
Rubella IgG
Rubella IgM
Toxo IgG
Toxo IgG Avidity
Toxo IgM

Login or register for a new account on the Lab Central customer portal. Here you can view assay specific package inserts for intended use, important safety information and manage your personalized lab metrics.

Visit Lab Central

A unified approach

Diagnostics at Abbott offers a complete portfolio of integrated solutions including Core Laboratory, Molecular, Point of Care, Rapid Diagnostics and Transfusion Medicine.

Explore diagnostics at Abbott

Explore

Immunoassays

Abbott's high-quality immunoassay menu helps laboratories meet requirements to be reliable, accurate and precise.

Explore Immunoassays

Mild Traumatic Brain Injury

Learn how Abbott has helped physicians evaluate suspected mild traumatic brain injury (mTBI).

Learn about mtbi

Alinity Family

Discover how Alinity uses powerful technology to help redefine and improve operational productivity and confidence in your laboratory.

Get to know alinity
References
  1. Bbosa, Nicholasa; Kaleebu, Pontianoa,b; Ssemwanga, Deogratiusa,b. HIV subtype diversity worldwide. Current Opinion in HIV and AIDS 14(3):p 153-160, May 2019. | DOI: 10.1097/COH.0000000000000534.
  2. Global hepatitis report 2024: action for access in low- and middle-income countries. Geneva: World Health Organization; 2024.
  3. Syphilis.”World Health Organization, World Health Organization, www.who.int/news-room/fact-sheets/detail/syphilis. Accessed 14 Aug. 2024.
  4.  Institute of Medicine Forum on Microbial Threats. Infectious Disease Emergence: Past, Present, and Future.
Logo Image

©2025 Abbott. All rights reserved.

All trademarks referenced are trademarks of either the Abbott group of companies or their respective owners. Any photos displayed are for illustrative purposes only. Any person depicted in such photos may be a model. Please read the Legal Notice for further details.

All ARCHITECT analyzers, Alinity hq, CELL-DYN Ruby and CELL-DYN Emerald 22 AL instruments are Class I laser products. ACCELERATOR APS and ACCELERATOR a3600 are Class II laser products.

The Alinity, ARCHITECT and CELL-DYN systems are intended for performing in vitro diagnostic assays on samples of human origin. Read the instructions in the system manuals and labeling and/or reagent instructions carefully.

This website contains general information about our products sold worldwide. Product availability varies by country. For product availability in your country, please contact your local representative from Abbott. Certain products described or certain features of some products described on this global page might not be commercially available in your country. Content is intended for healthcare professionals only.

You are about to exit the Abbott family of websites for a 3rd party website

Links which take you out of Abbott worldwide websites are not under the control of Abbott, and Abbott is not responsible for the contents of any such site or any further links from such site. Abbott is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott. The website that you have requested also may not be optimised for your screen size.

Do you wish to continue and exit this website?

You are about to enter an Abbott country or region specific website.

Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.

Do you wish to continue and enter this website?

NO